We have innovative kinase libraries (3X1000 compounds) and we´re looking for a partner/provider to further profile active compounds in in-vitro assay. The idea is to combine our design and synthesis expertise with a biology platform working into a partnership model (share risk model) and move the best compounds into clinic.